Brief: Devyser Q4 Sales SEK 34.2 Million

Devyser Diagnostics AB

21/02/2023 06:38

Feb 21 (Reuters) - Devyser Q4 adjusted free cash flow SEK -13.4 million.
* Q4 net income SEK -16.7 million
* Q4 adjusted EPS SEK -1.04
* Q4 EBIT SEK -25.9 million
* I am confident that we will achieve our important financial target of
generating an operating margin of more than 20% starting sometime in
2024/2026, CEO says